1. A randomised phase II study evaluating the efficacy and safety of subcutaneously administered ustekinumab and guselkumab in patients with active rheumatoid arthritis despite treatment with methotrexate. Issue 5 (13th January 2017) Authors: Smolen, Josef S; Agarwal, Sandeep K; Ilivanova, Elena; Xu, Xie Lillian; Miao, Ye; Zhuang, Yanli; Nnane, Ivo; Radziszewski, Waldemar; Greenspan, Andrew; Beutler, Anna; Baker, Daniel Journal: Annals of the rheumatic diseases Issue: Volume 76:Issue 5(2017) Page Start: 831 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗